Apply Now

News » Archives » November 2016

Why Don’t Patients Listen to their Doctors?

Author: Arnie Phifer

A new Notre Dame research program looks for solutions to the problem of medical nonadherence As part of the launch of a new research program in Health-Related Behavioral Sciences, the University of Notre Dame’s Advanced Diagnostics & Therapeutics initiative has made its first award to support an investigation of why...

Turning Ideas into Reality for Colon Cancer Research

Author: Jenna Bilinski

In July, 2014, Mike Patterson received some news that changed his life forever. He was diagnosed with stage four colon and liver cancer. “They didn’t give me a lot of hope,” recalled Patterson. Like many patients after receiving such a diagnosis, Mike asked for a second opinion. However, he was...

Eli Lilly Faculty Fellowship Provides Drug Discovery Experience

Author: Brandi Klingerman

Notre Dame Researcher Developing Medication Delivery System to Combat Diabetes Diabetes is a metabolic disease in which the body has an inability to produce enough insulin. In the United States alone, it is estimated that the illness affects nearly 30 million diagnosed and undiagnosed people, and treatment often includes patients...

Illuminating Ovarian Cancer Surgery

Author: Angela Cavalieri

One in 77 women will develop ovarian cancer in her lifetime.  Because ovarian cancer has no defined symptoms, most women will be diagnosed at a late stage of the disease where metastatic lesions are found dispersed throughout the abdomen.  Ovarian cancer is currently the fifth most common cause of cancer-related...

New Discovery Paves Way for Pancreatic Cancer Treatment

Author: Jessica Sieff

Pancreatic cancer, the third leading cause of cancer-related deaths, is projected to be the second by the year 2030, according to a study in the journal of Cancer Research. The five-year survival rate is only 8 percent, making it the only major cancer with a survival rate in the single...

Before a cure, a crusade to stop lung cancer from spreading

Author: Jessica Sieff

The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected result in an estimated 158,080 deaths in 2016. Although drugs are currently available to fight lung cancer, drug discovery challenges persist because treatment options are limited. Not only is...

Notre Dame Researchers Receive CTSI Pilot Research Grants

Author: Brandi Klingerman

Indiana CTSI grants encourage use of core facilities throughout the State The Indiana Clinical and Translational Sciences Institute (CTSI) announced that University of Notre Dame researchers have been awarded grants through the CTSI Pilot Funding program. The program is intended to promote the use of technologies and expertise available through...